Reduction of [ 18F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma

Molecular Imaging and Biology

Volumn 13, Issue 2, 2011, Pages 227-231

  Yamane, Tomohiko ^a   Kikuchi, Masahiro ^b   Shinohara, Shogo ^b   Senda, Michio ^a  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

18F fluoromisonidazole ( 18F FMISO); Head and neck cancer; Hypoxia; Neoadjuvant chemotherapy; Positron emission tomography (PET)

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOXIA; MALE; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORINE RADIOISOTOPES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MISONIDAZOLE; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 79955935104     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0365-2     Document Type: Article

References (19)

1. Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18-24 (Pubitemid 41503384)
2. 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70:1219-1228
3. Thorwarth D, Eschmann SM, Paulsen F, Alber M (2007) Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys 68:291-300 (Pubitemid 46589864)
4. Lee NY, Mechalakos JG, Nehmeh S et al (2008) Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 70:2-13 (Pubitemid 350251039)
5. Kim K, Wu HG, Kim HJ et al (2009) Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck 31:1121-1128
6. Paccagnella A, Ghi MG, Loreggian L et al (2009) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol. doi:10.1093/annonc/mdp573
7. 18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 75:101-108
8. 18F]fluoromisonidazole. Nucl Med Biol 32:553-558
9. 18F]FDG module. Nucl Med Biol 32:899-905
10. Kodaira T, Fuwa N, Tachibana H, Hidano S (2006) Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer. Anticancer Res 26:2265-2268 (Pubitemid 43980184)
11. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
12. 18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans- Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24:2098-2104
13. 18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 14:2623-2630
14. Rajendran JG, Schwartz DL, O'Sullivan J et al (2006) Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12:5435-5441 (Pubitemid 44497258)
15. 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253-260
16. 18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 50:2209-2224
17. Kubota K, Tada M, Yamada S et al (1999) Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med 26:750-757 (Pubitemid 29338663)
18. 18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer 7:113
19. 18F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys 70:235-242